CogniTrack
Alzheimer
We use the power of science for a brighter future, a clearer diagnosis, and a better life. This is not just a technology, it is an investment in human life.
Ongoing project
.png)
CogniTrack
Alzheimer
Ongoing project
Alzheimer
Supported
Traditional tests are inadequate in detecting early signs of Alzheimer's. VH- Alzheimer combines virtual reality (VR), artificial intelligence and biosensor technologies to assess cognitive functions in a VR environment with real-world scenarios, capturing the first signs of the disease.
Lack of Early Diagnosis and Inadequate Tools
Dementia is usually advanced by the time symptoms are noticed. Traditional diagnostic methods rely heavily on subjective assessments and clinical observations, making it difficult to detect early symptoms. Furthermore, the lack of standardized tools based on objective biomarkers limits accurate and timely diagnosis. This negatively impacts the quality of life of both individuals and families, leading to missed opportunities for earlier intervention.
Dementia is usually advanced by the time symptoms are noticed. Traditional diagnostic methods rely heavily on subjective assessments and clinical observations, making it difficult to detect early symptoms. Furthermore, the lack of standardized tools based on objective biomarkers limits accurate and timely diagnosis. This negatively impacts the quality of life of both individuals and families, leading to missed opportunities for earlier intervention.
Odaklanma süresi, dikkat dağılmasına karşı direnç ve seçici dikkat becerileri.
Kısa ve uzun süreli bellek kapasitesi ile bilgiyi hatırlama ve işleme yetisi.
Mekânsal algı, yön bulma ve nesneler arası ilişkileri anlama.
Problem çözme, karar verme, planlama ve bilişsel esneklik becerileri.
Beyond Traditional Testing
Alzheimer's Assessment
Comprehensive Cognitive Analysis
We Are Following the Traces of Alzheimer's
The assessment process targets the basic cognitive skills that an individual needs in daily life.
Attention span, selective attention skills and focus are measured.
Short-term and long-term memory capacity and the ability to remember and process information are evaluated.
Complex thinking processes such as problem solving, decision making, planning and cognitive flexibility are analyzed.
Problem solving, decision making, planning and cognitive flexibility skills.
Specially developed Virtual Navigation (SPA) tasks are used to measure an individual's spatial orientation and spatial memory.
New Generation Diagnostic Approach with Artificial Intelligence and VR
CogniTrack Dementia combines artificial intelligence and VR technologies to provide an innovative solution that detects early neurobiological signs of dementia. By analyzing eye movements and cognitive processes in real time, the system enables early diagnosis and provides diagnostic support to experts based on objective, scientific data. In this way, the disease process is managed more effectively and treatment plans can be personalized to the individual's needs.
Dementia
The Silent Epidemic of the Modern World
Dementia is a neurological disease that affects millions of people worldwide. As of 2024, 55 million people worldwide are living with dementia, with approximately 10 million new cases diagnosed each year. Alzheimer's disease, the most common form of dementia, accounts for 50% to 70% of all dementia cases. Alzheimer's is a progressive neurological disease that causes memory loss, impaired thinking skills, and loss of independence in daily activities. Studies show that the rate of Alzheimer's in individuals over the age of 65 ranges from 3% to 11%, while it reaches rates as high as 20% to 47% in individuals over the age of 85. In addition, the risk of Alzheimer's doubles every five years after the age of 65.
These diseases, which gradually lead to a decline in cognitive functions, seriously reduce the quality of life of individuals and increase the cost of care. Research shows that early diagnosis and effective care management have the potential to save 1 trillion USD annually. Therefore, innovative solutions for both dementia and Alzheimer's are a great need.
CogniTrack Dementia is a VR-based platform developed for the early diagnosis and management of dementia and Alzheimer's. It offers a fast, non-invasive and user-friendly solution through scientifically validated cognitive tests and games. This platform helps individuals maintain their cognitive health while providing an effective assessment process for physicians. CogniTrack Dementia aims to relieve the burden on individuals and healthcare systems by offering a comprehensive approach to combating Alzheimer's and dementia.
.png)
Anywhere, Anytime
Digital Check-Up
CogniTrack offers an innovative digital check-up solution that goes beyond the limitations of traditional tests and provides regular follow-up that can be accessed from anywhere.
Customized tests and reports are provided based on each individual's cognitive performance.
Moving beyond one-time assessments, changes in cognitive functions are monitored periodically.
Early-stage symptoms of Alzheimer's are detected in details that cannot be detected in traditional tests.
Performance in the VR environment is analyzed with multidimensional data such as eye movements, reaction time and spatial strategies.
Early Diagnosis of Alzheimer's
Why Is It Important?
Alzheimer's disease is a neurodegenerative disease that causes progressive loss of brain cells and causes serious deterioration in cognitive functions over time. However, slowing down this process and preserving the individual's quality of life becomes possible with early diagnosis. Research shows that changes in brain tissue begin 15-20 years before symptoms of the disease appear.
Alzheimer's diagnosed at an early stage allows symptoms to be slowed down.
Hippocampal atrophy and shrinkage of the entorhinal cortex begin in the early stages of Alzheimer's, and early diagnosis can slow the loss of these areas.
The individual's independent living skills are preserved for a longer period of time, and their functionality in daily activities increases.
Biomarkers and neuroimaging techniques can detect Alzheimer's disease before clinical symptoms appear, enabling personalized treatment plans
Early diagnosis helps the patient and family plan for the future, organize the care process and make living arrangements in a timely manner.
